Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
$1.65-1.43%
报价 2026-11-06
市值
$4.9M
EV
$1.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -74.8%
$1.05$6.55
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CDIOCardio Diagnostics Holdings, Inc. | $4.9M | -1.4% | +4900.0% | -555% | – | – | – | |
| IBOImpact BioMedical Inc. | $35.5M | -6.6% | – | -1,111.4% | – | – | – | |
| BCDABioCardia, Inc. | $12.9M | -4.5% | 0.0% | 0% | – | – | – | |
| TCRTAlaunos Therapeutics, Inc. | $6M | -5.4% | -84.3% | -28,133.3% | – | – | – | |
| ADXNAddex Therapeutics Ltd | $3.6M | -4.7% | – | 41.2% | – | – | – | |
| NRSNNeuroSense Therapeutics Ltd. | $3.2M | +20.4% | – | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $1.6M | +2.6% | +1118724.9% | -1,732.4% | – | – | – | |
| RADXRadiopharm Theranostics Limited | $1.2M | +7.9% | – | -39.4% | – | – | – | |
| MTNBMatinas BioPharma Holdings, Inc. | $508,224 | +2.6% | +46.0% | 0% | – | – | – | |
| 同行中位数 | – | – | +23.0% | -19.7% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。